phenylalanine and kb r8301

phenylalanine has been researched along with kb r8301 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chu, P; Hamada, H; Kato, K; Kipps, TJ; Takahashi, S	1

Other Studies

1 other study(ies) available for phenylalanine and kb r8301

Article	Year
Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells. Experimental hematology, 2007, Volume: 35, Issue:3 Topics: CD27 Ligand; Dose-Response Relationship, Drug; Humans; Hydroxamic Acids; Leukemia, Lymphocytic, Chronic, B-Cell; Metalloproteases; Phenotype; Phenylalanine; Protease Inhibitors; Solubility; T-Lymphocytes; Thiophenes; Tumor Necrosis Factor Receptor Superfamily, Member 7	2007

Article

Year

Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells.

Experimental hematology, 2007, Volume: 35, Issue:3

Topics: CD27 Ligand; Dose-Response Relationship, Drug; Humans; Hydroxamic Acids; Leukemia, Lymphocytic, Chronic, B-Cell; Metalloproteases; Phenotype; Phenylalanine; Protease Inhibitors; Solubility; T-Lymphocytes; Thiophenes; Tumor Necrosis Factor Receptor Superfamily, Member 7

2007